194 related articles for article (PubMed ID: 38712692)
1. Recent advances in micro/nanomotors for antibacterial applications.
Wang W; Luo H; Wang H
J Mater Chem B; 2024 May; 12(21):5000-5023. PubMed ID: 38712692
[TBL] [Abstract][Full Text] [Related]
2. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial micro/nanomotors: advancing biofilm research to support medical applications.
Jiang Z; Fu L; Wei C; Fu Q; Pan S
J Nanobiotechnology; 2023 Oct; 21(1):388. PubMed ID: 37875896
[TBL] [Abstract][Full Text] [Related]
4. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
5. Autonomous Treatment of Bacterial Infections
Arqué X; Torres MDT; Patiño T; Boaro A; Sánchez S; de la Fuente-Nunez C
ACS Nano; 2022 May; 16(5):7547-7558. PubMed ID: 35486889
[TBL] [Abstract][Full Text] [Related]
6. Infection microenvironment-related antibacterial nanotherapeutic strategies.
Wang Z; Liu X; Duan Y; Huang Y
Biomaterials; 2022 Jan; 280():121249. PubMed ID: 34801252
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
Mba IE; Nweze EI
World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
[TBL] [Abstract][Full Text] [Related]
8. Nanozymes used for antimicrobials and their applications.
Yang D; Chen Z; Gao Z; Tammina SK; Yang Y
Colloids Surf B Biointerfaces; 2020 Nov; 195():111252. PubMed ID: 32679446
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterials for alternative antibacterial therapy.
Hemeg HA
Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial Applications of Nanodiamonds.
Szunerits S; Barras A; Boukherroub R
Int J Environ Res Public Health; 2016 Apr; 13(4):413. PubMed ID: 27077871
[TBL] [Abstract][Full Text] [Related]
11. Broad-Spectrum Antimicrobial and Antibiofilm Activity of a Natural Clay Mineral from British Columbia, Canada.
Behroozian S; Svensson SL; Li LY; Davies JE
mBio; 2020 Oct; 11(5):. PubMed ID: 33024043
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial micro/nanomotors: current research progress, challenges, and opportunities.
Liu XY; Li RF; Jia J; Yu ZL
Theranostics; 2024; 14(3):1029-1048. PubMed ID: 38250044
[TBL] [Abstract][Full Text] [Related]
13. Nature-Inspired Micro/Nano-Structured Antibacterial Surfaces.
Jin E; Lv Z; Zhu Y; Zhang H; Li H
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731407
[TBL] [Abstract][Full Text] [Related]
14. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
[TBL] [Abstract][Full Text] [Related]
15. Nanomaterial in controlling biofilms and virulence of microbial pathogens.
Tungare K; Gupta J; Bhori M; Garse S; Kadam A; Jha P; Jobby R; Amanullah M; Vijayakumar S
Microb Pathog; 2024 Jul; 192():106722. PubMed ID: 38815775
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins.
Cascioferro S; Raimondi MV; Cusimano MG; Raffa D; Maggio B; Daidone G; Schillaci D
Molecules; 2015 Dec; 20(12):21658-71. PubMed ID: 26690095
[TBL] [Abstract][Full Text] [Related]
17. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
Natan M; Banin E
FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
[TBL] [Abstract][Full Text] [Related]
18. Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces.
Mi G; Shi D; Wang M; Webster TJ
Adv Healthc Mater; 2018 Jul; 7(13):e1800103. PubMed ID: 29790304
[TBL] [Abstract][Full Text] [Related]
19. Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives.
Panthi VK; Fairfull-Smith KE; Islam N
Int J Pharm; 2024 Apr; 655():124046. PubMed ID: 38554739
[TBL] [Abstract][Full Text] [Related]
20. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
Zacchino SA; Butassi E; Cordisco E; Svetaz LA
Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
